| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |